Relafen 750, the unique formulation of naproxen, offers a intriguing example from the biochemical pharmacy standpoint. This process of action, essentially involving inhibition of cyclooxygenase enzymes namely COX-1 and COX-2 – leads to significant reduction in prostaglandin synthesis. Within our biochemical framework, the drug's efficacy is direc